BRIEFING · UPDATED SEP 29, 2026
Short, dated news on the mushroom industry, functional mushrooms, cultivation, research and policy, with a source on every item. Educational only.
· INDUSTRY
The Functional Mushroom Council reports Q3 2026 capacity and formulation moves by member companies, including Monterey Nutra doubling the manufacturing footprint of its vertically integrated Watsonville facility.
Source: Vertical Farm Daily
· FUNCTIONAL
SPINS data for the 52 weeks ending Sept. 6, 2026 show dollar sales up 23.2% and units up 34.8%. Cognitive-health products were the largest segment at $153.5M.
Source: NutraIngredients
· CULTIVATION
NASS reports 636 million lb sold (down 5%) worth $922M. Specialty mushroom sales fell 21% to $75.0M, at an average of $4.56/lb. Growers plan 16% less filling area for 2026-27.
Source: USDA NASS
· POLICY
The American Mushroom Institute's 2026 policy report says modernized USDA mushroom grades and standards were published in the Federal Register for comment, and that USDA research on mushroom crop insurance is underway.
Source: American Mushroom Institute
· RESEARCH
A randomized, placebo-controlled preprint (n=109, ages 40-75, 8 weeks) reports modest improvements in visual attention, sleep quality and mood. It has not been peer reviewed yet.
Source: medRxiv
· INDUSTRY
Acquisitions such as Real Mushrooms buying Mushroom Science, and Giorgi Mushroom Co. buying L.F. Lambert Spawn Co., point to consolidation as inflation pressures consumers.
Source: FoodNavigator-USA
· POLICY
FDA found the seller's Amanita muscaria capsules, tincture and chocolate adulterated. FDA says Amanita muscaria and its constituents are not authorized in conventional food.
Source: FDA
Coming soon: email signup isn't open yet, and this form doesn't collect anything.